Form 4: Medpace CEO Sells Over $21 Million in Company Stock

Medpace Holdings CEO and 10% owner, August J. Troendle, sold 48,487 shares of common stock for approximately $21.9 million in a pre-arranged transaction.

Summary

• August J. Troendle, who serves as CEO, Director, and 10% owner of Medpace Holdings, Inc. (MEDP), sold 48,487 shares of the company's common stock.
• The transaction took place on July 28, 2025, at a weighted average price of $451.69 per share.
• The total value of the shares sold amounts to approximately $21,900,000.
• The sale was executed pursuant to a limit order placed by August J. Troendle during an open window period, indicating a pre-planned transaction.
• Following this transaction, August J. Troendle directly holds 962,615 shares of common stock.
• August J. Troendle also indirectly holds 4,733,019 shares through Medpace Investors, LLC, where he is the sole manager and controlling unit holder, though he disclaims beneficial ownership except to the extent of his pecuniary interest.
• The reported price is a weighted average, with individual share sales ranging from $450.00 to $454.96.

Sentiment

Score: 5

Explanation: The filing reports an insider sale by the CEO and 10% owner. While insider sales can sometimes be viewed negatively, this transaction was executed pursuant to a pre-arranged limit order, which mitigates the negative signal. The insider retains substantial direct and indirect holdings, suggesting no significant loss of confidence in the company.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale by a key insider, while pre-planned, could be interpreted by some shareholders as a signal, though the remaining substantial holdings suggest continued alignment.

Key Dates

Keywords

Medpace Holdings, MEDP, Insider Trading, Form 4, Stock Sale, August J. Troendle, CEO, Director, 10% Owner, Beneficial Ownership